German Ott

21PUBLICATIONS
220CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Predictive and prognostic markersCardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Oct 14, 2026
Neoantigenic receptor ROR1 promotes cell growth through diverse and complementary mechanisms.

|Feb 19, 2026
Repression of miR-29 via MYC leads to increased CD40 signaling in transformed follicular lymphoma.

Daniel Filip, Katerina Litzmanova, Androniki Michaelou

|Nov 07, 2025
Cyclin D1 rearranged diffuse large B-cell lymphoma-an evolving concept.

K S Kurz, A Zamo, C Drewes

|Sep 05, 2025
Current practice of pathologic response assessment following chemoimmunotherapy for non-small cell lung cancer (NSCLC) in Germany: first real-world data from the multicentre Re-GraDE study.

Felix Elsner, Christiane Kümpers, German Ott

|May 08, 2025
DNA Methylation Epitypes of Burkitt Lymphoma with Distinct Molecular and Clinical Features.

Nicole Thomas, Carlos A García-Prieto, Kostiantyn Dreval

|Apr 27, 2025
Morphological, immunohistochemical and molecular analysis of follicular dendritic cell sarcomas: L1CAM as a new diagnostic marker.

Selina Schelbert, Katja Maurus, Sabine Roth

Pageof 4

Frequent Collaborators

7 joint publications

Wolfram Klapper

5 joint publications

Reiner Siebert

4 joint publications

Sylvia Hartmann

3 joint publications

Alberto Zamò